ENTERTAINMENT

Coronavirus UK: Vaccinations could start in weeks, says Matt Hancock


Matt Hancock suggested today that the introduction of a coronavirus vaccination program could be just weeks away

Brits at risk could be vaccinated against coronavirus within a few weeks, Matt Hancock suggested again today as he vowed to take "personal control" of the largest vaccination campaign in British history.

The Health Secretary raised hopes last week when he said it was possible to distribute the Pfizer vaccine – which will likely be approved first – to high-risk groups from December 1.

But officials are waiting for the dab to get the green light from the UK drug watchdog, who is sifting through data from Pfizer's studies to make sure the vaccine is safe enough to administer to millions of people.

Mr Hancock said today he "still hopes" that this process will be completed in weeks and that British at risk could get a stab sometime next month as part of the first wave of crucial operation.

He added that he had "personal control" of the introduction, which could result in the NHS England delivering an unprecedented million doses each day.

Although the health minister – who still fails to deliver on his promise of 500,000 coronavirus tests a day by the end of October – admitted it would be "one of the largest civilian projects in history".

In addition to grappling with the massive Covid-19 vaccination program, the NHS is being asked to give 30 million flu shots – most of all time – to protect healthcare from the dual threats of both viruses.

During a round of interviews this morning, Hancock said on the BBC Radio 4 Today program, “We have changed the law to change the number of clinically qualified people who can vaccinate as this will be one of the largest civilian projects in history.

'It will be run by the NHS, which of course has the annual experience of a mass flu vaccination program, and it will involve general practitioners, the wider NHS and hospitals.

"We have this huge flu vaccine program and then the likely big numbers when it comes out and I stress the 'if' will be for a Covid vaccine next year, but we still hope we can get something going." in December this year. & # 39;

When asked if he would take personal control of the launch, the Minister of Health said, “Yes. I've reported weekly to the Prime Minister, the NHS will take control of the delivery and they'll report to me. We have some of the best people on the NHS who spend all of their time on it. & # 39;

Mr Hancock said that once a Covid-19 vaccine gets the green light, dozens of mass coronavirus vaccination centers will be set up across the country in the coming weeks while firefighters are trained to help deliver the vaccinations.

General practitioners have been instructed to organize the first wave, using community centers, village halls, and practices themselves to deliver the shocks to caregivers and the elderly as early as the next month.

The NHS is setting up a number of much larger venues to inject millions of others once those high on the priority list have received the nudges.

Empty NHS Nightingale hospitals and sports centers, including the Derby Arena, are slated to line up as possible venues. Firefighters are also encouraged to join an army of 40,000 additional workers.

Plans are being drawn up for mass vaccination sites across the country to deliver vaccinations to millions of Britons in record time (Image: library picture)

Plans are being drawn up for mass vaccination sites across the country to deliver vaccinations to millions of Britons in record time (Image: library picture)

It was announced last night that the NHS will expand its winter flu shots to millions more this winter.

Mr. Hancock told Sky News, “Typically 15 million people are vaccinated against flu. This year it will be 30 million – the largest number in history.

& # 39; We hope that we will also have a Covid vaccination program alongside. It's going to be a tremendous effort, but I know the NHS is ready for it. & # 39;

He reiterated the comments during an interview with BBC Breakfast in which he said, "I am not denying that it is an enormous amount of work for the NHS and I am very grateful for the incredible change they and we have made this year . " We still have to deliver this winter.

"Of course there is pressure on the NHS this year – by God there is pressure thanks to Covid – and for everyone who works in the NHS, I would like to thank you for the work you are doing."

According to the Health Service Journal, full Covid vaccination is expected to begin in the New Year, although at-risk Brits may be able to begin vaccinating Covid before that.

The vaccination campaign will likely include conference centers and drive-through locations as used by the Covid testing program.

According to the Telegraph, Derby City Council has confirmed it is negotiating with the government over plans to use the Derby Arena as a vaccination site.

It could become one of the first places the vaccine will be given by mid-December.

Every major city will have its own mass vaccination center, according to Sun

The newspaper reports that 50 locations are planned in sports arenas, town halls and NHS Nightingale hospitals, as well as 1,000 smaller locations across England.

In the meantime, the NHS is slated to launch a major recruiting campaign to hire up to 40,000,000 people to give the Pfizer vaccine.

Trained doctors and nurses are high on their wish lists.

But retired doctors and nurses, as well as those with first aid skills, including firefighters, police officers and members of the armed forces, are also being targeted in the recruitment campaign, Sun reports.

The vaccination army that is being trained will be supported by an additional 30,000-strong team of volunteers from St. John Ambulance, the paper adds.

The vaccination army that is being trained is supported by an additional 30,000-strong team of St. John Ambulance volunteers (Image: Library Image)

The vaccination army that is being trained is supported by an additional 30,000-strong team of St. John Ambulance volunteers (Image: Library Image)

The final trial results from Pfizer and BioNTech showed that only eight out of more than 20,000 people who received the vaccine received the coronavirus, compared to 162 people who were given a fake sting

The final trial results from Pfizer and BioNTech showed that only eight out of more than 20,000 people who received the vaccine received the coronavirus, compared to 162 people who were given a fake sting

The final trial results from Pfizer and BioNTech showed that only eight out of more than 20,000 people who received the vaccine received the coronavirus, compared to 162 people who were given a fake sting

The final trial results from Pfizer and BioNTech showed that only eight out of more than 20,000 people who received the vaccine received the coronavirus, compared to 162 people who were given a fake sting

Pfizer and BioNTech's vaccine uses genetic material called RNA from the coronavirus to trick the body into making the "spike" proteins that the virus uses to attach to cells in the body, and then trains that Immune system to attack the spikes

Pfizer and BioNTech's vaccine uses genetic material called RNA from the coronavirus to trick the body into making the "spike" proteins that the virus uses to attach to cells in the body, and then trains that Immune system to attack the spikes

Scientists warn that the final results for the Oxford vaccine will not be available for weeks

Oxford University's Covid vaccine is unlikely to be used in the UK before Christmas, as the scientists who lead the project said they don't expect results to be available to regulators until December.

The researchers today published a study confirming that their vaccine candidate elicits an immune response in older people, who are at greatest risk for severe Covid-19, and that studies have not found any safety issues.

However, the length of time for the sting, which number 10 has ordered 100 million doses for and which is considered to be one of the UK's greatest hopes of ending the epidemic, could stretch to early 2021 before people start injecting.

Professor Andrew Pollard, director of the Oxford Vaccine Group, said today he was "optimistic" that the study will provide results showing how well it protects against Covid before Christmas. However, the following process of licensing it and then delivering it to clinics is "out of our control" and could take weeks longer, he said, which would postpone delivery to next year.

Scientists behind the project this morning released the results of an early trial with the sting which found two doses to produce strong signs of immunity in 99 percent of people of all ages.

The second phase study included 560 volunteers, most of whom were White and British, and showed that people of all ages appeared to respond equally well to the bump. It complements data released in July suggesting it would work safely for children under the age of 55. Studies in people with serious health problems and other ethnic groups are ongoing.

It's another breakthrough in the race to develop a vaccine to prevent Covid after it was found that the shocks carried out by Moderna and Pfizer and BioNTech were around 95 percent effective over the past week.

The Oxford results come from an earlier stage of the studies and therefore cannot estimate how well the vaccine protects against Covid, but it is a positive step nonetheless. Research showed that people of all ages developed neutralizing antibodies – virus-destroying substances of the immune system – within 28 days of their first vaccine dose, which were further increased after the second dose.

It was found that the vaccine caused more side effects than a false prick, but that they were "mild" and more common in young people than in older participants. Within the first week after the injection, more than eight in ten under 55-year-olds said that their arm was injured and that they later experienced tiredness, muscle pain or headache. Experts said this could only be because younger people's immune systems are more active and likely to be overreacting.

The UK Medicines Agency announced earlier this week that it was waiting for Pfizer to submit the full results of its definitive Covid-19 vaccine study after the drug company claimed it was safe, 95 percent effective and works in the elderly, those most at risk of dying from the disease.

Best known for producing Viagra, the US company announced that it would submit the required data to regulators in America and the UK "within days," which raises hopes that the UK will get its big of the Army backed operation to vaccinate millions of people could start soon as December 1st.

The UK Medicines Agency MHRA has carried out an "ongoing review" of the vaccine and could therefore complete the approval process within a few days of receiving the application from Pfizer and BioNTech, the German company involved in making the sting.

Dr. June Raine, the agency's chief executive officer, said, “The results reported by Pfizer are very encouraging and complement last week's announcement.

"We look forward to receiving the full results of the studies as soon as possible. After that, we will scrutinize the evidence of the vaccine's safety and effectiveness."

The UK has already pre-ordered 40 million doses of the vaccine and is expected to receive 10 million in the next month. The NHS is preparing to distribute it within 14 days.

Professor Stephen Powis, the medical director of NHS England, said this week the health service was working "incredibly hard" to prepare.

The final trial results from Pfizer and BioNTech showed that only eight out of more than 20,000 people who received the vaccine received the coronavirus, compared to 162 people who were given a fake sting.

A total of 10 people received severe Covid-19, one of whom had received the real vaccine.

An independent safety committee has "reported no serious safety concerns with the vaccine" since the final phase of the trial began in July, Pfizer said.

Side effects were limited – the most common were fatigue, which 3.8 percent of people had, and headache (2 percent).

The updated data from Pfizer and BioNTech should reassure critics, but the government is still faced with the mammoth task of transporting and storing the pile. It may take expensive specialty freezers and huge supplies of dry ice to keep it at the required -70 ° C (-94 ° F).

The announcement is an improvement on Pfizer's earlier estimate that the vaccine was 90 percent effective, and comes just days after competitor Moderna claimed its own shock was 94.5 percent effective.

Unlike Pfizer's shock, Moderna's shock can be stored in normal fridges and freezers between -20 ° C (8 ° C) and 8 ° C (46 ° F).

Health Secretary Matt Hancock confirmed earlier this week that the UK would receive 5 million doses of the shock from March 2021 if approved by regulators.

The deal is expected to cost the UK between £ 24 ($ 32) and £ 28 ($ 37) per dose – while the US, which pre-ordered the burst months ago, will pay just $ 15 (£ 11.32) and is expected to have access will be received next month when health chiefs approve the push.

The UK is expected to pay around £ 15 per stab for the Pfizer vaccine.

Meanwhile, the home-grown vaccine developed by Oxford University and Astrazenica could cost as little as £ 2.23. The results for the UK Jab are expected in December.

(tagsToTranslate) Dailymail (t) News (t) NHS Nightingale Hospitals (t) NHS (t) Coronavirus Vaccine Research (t) Matt Hancock (t) Coronavirus (t) UK Government News and Updates in the UK Cabinet